Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you consider consolidative RT in patients with metastatic bladder cancer after near complete response after Keytruda?
Answer from: Radiation Oncologist at Community Practice
Generally, no I wouldn't, as I can't quantify the risk-to-benefit ratio given the paucity of data.
Sign in or Register to read more
20304
Related Questions
How would you treat a patient with retroperitoneal lymphadenopathy that has been biopsy proven metastatic seminoma, who is not a candidate for orchiectomy, RPLND, or systemic therapy?
What is your preferred dose to gross lymph nodes when treating non-metastatic high-risk prostate cancer?
How often do you utilize intrafraction motion tracking when treating prostate cancer?
What are the realistic, modern 10-year survival curves for localized prostate cancer given the improvements we have made in diagnostics and treatment?
For patients with oligo-progressive prostate cancer fit for metastasis-directed therapy but ineligible for radiotherapy or surgery, how do you decide between the types of ablation available?
What are the indications for postoperative radiation for extramammary Paget's disease?
Is there any evidence that ivermectin suppresses the PSA level in prostate cancer?
In asymptomatic patients with castrate resistant prostate cancer who have failed chemotherapy and have progressive PSMA-avid vertebral body metastases, when do you prescribe lutetium 177 (Pluvicto) vs prophylactic spinal radiation?
How would you plan sequencing of an MRI-directed prostate nodule micro-boost when doing a sequential plan?
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?